Analysts Boost Targets for AXA Following Strong Financial Outlook

AXA's 2025 results show robust profit growth, prompting major banks to raise share price targets. Strong Life & Health performance and increased shareholder returns underpin optimism.

Institutional confidence in French insurance giant AXA has strengthened significantly after the company unveiled its 2025 results. A cluster of major banks have revised their share price targets upward, responding to better-than-expected profit growth and a confident forward-looking statement. The robust figures have prompted a closer look at what is driving this analyst optimism.

Financial Performance Underpins Confidence

A review of the annual report reveals the foundation for the positive sentiment. AXA met market expectations with gross written premiums reaching €116 billion, marking a 6% increase. The core operational profit growth, excluding the divested asset management unit AXA IM, stood at 9%. The group's net income surged by 26% to €9.8 billion, a figure substantially influenced by one-off gains from the sale of the asset management division. A return on equity of 16% further highlights the company's current profitability.

Particular momentum was observed in the Life & Health business, where revenues advanced by 8% to €56.5 billion. This performance was largely propelled by the health insurance segment, which saw premium growth of 17%.

Revised Price Forecasts Reflect Sector Approval

Market experts from leading investment banks are united in their view that AXA's core operations are performing smoothly. Analysts at Berenberg now lead with a revised price target of €50.70. RBC Capital Markets and Goldman Sachs have both raised their expectations to €48 per share. These institutions emphasize the company's sustainable revenue momentum and operational enhancements, which they believe support a solid growth trajectory. Deutsche Bank has also aligned with this positive trend, making a slight adjustment to its target, now set at €45.50.

Shareholder Returns and Forward Guidance

Investors are set to benefit directly from this strong performance. The company's board has announced an 8% increase in the dividend to €2.32 per share. Furthermore, a new share buyback program has been initiated, with a total value of up to €1.25 billion. Looking ahead to the 2026 fiscal year, management has expressed ambitious targets, anticipating growth in adjusted earnings per share at the upper end of its 6% to 8% goal range.

The current share price is €39.51, trading closely to its 50-day moving average of €39.44. Whether the equity can gather enough momentum to challenge its 52-week high of €43.39 may also depend on upcoming strategic communications. In September 2026, leadership is scheduled to present a new three-year plan covering the period until 2029, which is expected to provide further catalysts for the stock's valuation.